Scale Your Clinical Trials with a
Globally Aligned CRO Partner

Helping Indian Sponsors Generate Globally Relevant Clinical Data

As Indian biopharma companies increasingly expand into U.S., EU, and international markets, the ability to generate globally aligned clinical data has become increasingly important. InoRx helps sponsors execute studies with operational rigor, regulatory awareness, and quality systems designed to support broader global utility.

Feasibility, Study Conduct, and Patient Retention

Phase 1 & Early-Phase Excellence

Multi-Geography Regulatory and Advisory Support

High-Throughput Clinical Capacity

Quality-Centered Clinical Execution

Inspection-Ready Execution

Ready to Execute Your Next Trial?​

Partner with a next-generation CRO built to accelerate your time-to-market.

Stabilizing a Distressed Medical Device Rescue Study

Experienced project management intervention resolved site-level operational, compliance, data, training, and vendor issues, helping return a 2,000-participant medical device study to on-track execution

Meeting a Late Regulatory Mandate Rescue Study

Rapid Phase I site activation, participant pre-screening, and coordinated execution helped a sponsor meet a late regulatory mandate within a highly compressed timeline

Delayed Startup to Success Rescue Study

Rapid site activation and flexible enrollment capacity helped recover a delayed study, absorb additional participants, and complete study activities before the reference clinical trial material expired

COVAXIN

Learn how InoRx supported the rapid development and launch of COVAXIN during a global public health emergency. This case study highlights our approach to accelerated enrollment, multi-phase study execution, site management, and regulatory alignment—all under extreme operational pressure.

Pharmacokinetic

Discover how InoRx successfully executed a pharmacokinetic study under critical timelines. Learn how our team overcame operational challenges, ensured data integrity, and supported regulatory submission—all while meeting accelerated deadlines.